|
 |
EfavirenzThis page contains recent news articles, when available, and an overview of Efavirenz but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Efavirenz (when available) Efavirenz (dideoxyinosine, ddI) is an oral nucleoside reverse transcriptase inhibitor (NRTI). It is a synthetic purine derivative and, similar to zidovudine, zalcitabine, and stavudine. Efavirenz was originally approved specifically for the treatment of HIV infections in patients who failed therapy with zidovudine. Currently, the CDC recommends that Efavirenz be given as part of a three-drug regimen that includes another nucleoside reverse transcriptase inhibitor (e.g., lamivudine, stavudine, zidovudine) and a protease inhibitor or efavirenz when treating HIV infection. For use in combination treatment of HIV infection (AIDS) Mechanism Of Action: Similar to zidovudine, Efavirenz inhibits the activity of viral RNA-directed DNA polymerase (i.e., reverse transcriptase). Antiviral activity of Efavirenz is dependent on intracellular conversion to the active triphosphorylated form. The rate of Efavirenz phosphorylation varies, depending on cell type. It is believed that inhibition of reverse transcriptase interferes with the generation of DNA copies of viral RNA, which, in turn, are necessary for synthesis of new virions. Intracellular enzymes subsequently eliminate the HIV particle that previously had been uncoated, and left unprotected, during entry into the host cell. Thus, reverse transcriptase inhibitors are virustatic and do not eliminate HIV from the body. Even though human DNA polymerase is less susceptible to the pharmacologic effects of triphosphorylated Efavirenz, this action may nevertheless account for some of the drug's toxicity. News Articles on Efavirenz New resistance becoming rarer as more patients achieve undetectable HIV viral load - 05 Jan 2010 Older drugs from the NNRTI class (efavirenz and nevirapine) are the antiretroviral agents most vulnerable to resistance. “However even for this drug classâ€?, ... Aidsmap Rilpivirine/Truvada Combo Pill Could Earn $2 Billion Yearly - Jan 4, 2010 Tibotec is hoping the Phase III studies prove the new drug is as effective as Sustiva (efavirenz)—but with fewer side effects—in first-time treatment takers ... AIDSmeds.com HIV/AIDS Treatment News Mylan Inc awarded tentative FDA approval for NDA for Efavirenz Tablets for HIV ... - Dec 23, 2009 Efavirenz is a non-nucleoside reverse transcriptase inhibitor (nNRTI) that has been found to be effective in many combination regimens for the treatment of ... Trading Markets (press release) PBS List Sees Addition of New HIV Medicine - Jan 1, 2010 Under the Pharmaceutical Benefits Scheme, tenofovir will now be listed alongside emtracitabine and efavirenz, commercially marketed as Atripla, ... TopNews New Zealand Flu vaccine extended - Dec 31, 2009 In other changes that take effect from today, a pill containing tenofovir with emtracitabine and efavirenz will be added to the Highly Specialised Drugs ... The Australian A Pair of Names in the News - Dec 22, 2009 While the Efavirenz news will have a decidedly lower financial impact that the potential for generic Vytrorin sales, it still marks a positive win for Mylan ... TheStreet.com (subscription) Reyataz and Sustiva Co-Pay Programs Expanded - Dec 18, 2009 Atripla (which contains efavirenz, tenofovir and emtricitabine) will continue to be a part of the older program for the time being, which asks people to ... AIDSmeds.com HIV/AIDS Treatment News TB, pregnancy, most common reasons for treatment changes in African study - Dec 10, 2009 The finding calls attention to the dilemma facing physicians who need to decide whether to prescribe nevirapine (Viramune) or efavirenz (Sustiva), ... Aidsmap Most NNRTI-experienced patients in southern Africa will benefit from etravirine - Dec 17, 2009 Nearly all patients in southern Africa who have received treatment with the NNRTIs efavirenz or nevirapine would benefit from therapy with etravirine, ... Aidsmap The Top Five Biotech Innovations of the 2000s - Dec 14, 2009 2) HIV therapies such as Gilead Sciences' combination of efavirenz, emtricitabine, and tenofovir (Atripla). 4) Therapies for hepatitis C such as Vertex ... Xconomy Widespread Crusted Lesions in a Patient With HIV—Diagnosis - Dec 21, 2009 The patient started antiretroviral therapy (zidovudine, 600 mg/d; lamivudine, 300 mg/d; and efavirenz, 600 mg/d) and treatment with amphotericin B (1 mg/kg ... Archives of Dermatology UNITAID approves patent pool for HIV drugs - Dec 15, 2009 Potential combinations of interest will include a wider selection of three-drug combinations that include tenofovir and efavirenz, in order to promote ... Aidsmap Study Identifies Viread And Emtriva As The Preferred Initial Treatment For HIV ... - Dec 10, 2009 Emtriva or Ziagen and Epivir along with either Norvir (ritonavir)-boosted Reyataz (atazanavir), a protease inhibitor, or Sustiva (efavirenz), an NNRTI. ... The AIDS Beacon (blog) Business news briefs - Dec 23, 2009 Mylan Inc. said it received tentative regulatory approval to market pediatric dosages of Efavirenz tablets for treating HIV infection. ... Pittsburgh Post Gazette SEXUALLY TRANSMITTED DISEASES:- THEIR NATURE AND CURE - THIRD PUBLICATION - Dec 18, 2009 Examples of Anti-retroviral drugs are: Zidovudine (AZT or 31 Azido 31 deoxy thymidine) or retrovir, Nevirapine, Didanosine, Efavirenz, Lamivudine, ... Modern Ghana 美洲篇：巴西å?¢æ‹‰ä¹‹å?Ž - Jan 4, 2010 ...塞拉任è?Œå?«ç”Ÿéƒ¨é•¿æœŸé—´æœ€ä»¤äººæ€€å¿µçš„æ”¿ç»©å°±æ˜¯å†³å®šæ‰“ç ´efavirenz(默克公å?¸ç”Ÿäº§çš„抗艾è?¯)的专利æ?ƒï¼Œè®©è‰¾æ»‹åœ¨å·´è¥¿å¾—到控制。但是有人担忧身为康乃尔大å¦ç»?济å¦å?šå£«çš„塞拉 ... 南方报业 Mylan Labsæ–°è?¯èŽ·å‡†çº³å…¥é˜²æ²»çˆ±æ»‹ç—…紧急救助计画 - Dec 22, 2009 ...(MYL) 18.91 : Mylan Labs宣布，å?å…¬å?¸Matrix LaboratoriES Limited申请上市的新è?¯Efavirenz获得美国FDAåˆ?æ¥æ ¸å‡†ï¼Œçº³å…¥æ€»ç»Ÿçš„防治爱滋病紧急救助计 ... 凤凰网 政府è?¯ç‰©ç¦?利计划新增治疗爱滋病è?¯ç‰© - Dec 31, 2009 ...æ?®æ¾³æ–°ç¤¾æŠ¥é?“，这次新列入政府è?¯ç‰©ç¦?利计划（PBS）的è?¯ç‰©æ˜¯tenofovir（包括emtracitabineå’Œefavirenz），å?³ä¸€èˆ¬å•†ä¸šä¸Šæ‰€ç§°çš„Atripla。它们专门用于治疗艾滋病毒æ?ºå¸¦è€… ... 大纪元 Retrospectiva 2009: Ministro da Saúde José Gomes Temporão disse que ... - Dec 30, 2009 Em março o ministro da Saúde José Gomes Temporão afirmou em entrevista à TV UOL que o licenciamento compulsório do Efavirenz, realizado em 2007 pelo governo ... Agência de Notícias da Aids muita saúde, expectativas do setor - Jan 2, 2010 Ainda, iniciamos em 2009 a produção nacional do genérico do Efavirenz, usado por pacientes portadores do vÃrus HIV. Na ampliação do acesso, ... JB Online 2010ë…„ 8ê°œ 블ë¡?버스터 ì‹ ì•½ 출시 - Dec 29, 2009 J&Jì?˜ '릴피비린'ì?€ 차세대 NNRTI HIV ì¹˜ë£Œì œë¡œ NNRTI ì €í• ê· ì£¼ì—?ë?„ 효과ì ?ì?´ë©° ìž„ìƒ?ì—?ì„œ '서스티바'(Sustiva, efavirenz)보다ë?„ 우월한 효과와 ì•ˆì „ì„±ì?„ 보였다. ... 디지틀보사 2010 com muita saúde: expectativas do setor - Jan 3, 2010 Ainda, iniciamos em 2009 a produção nacional do genérico do EFAVIRENZ, usado por pacientes portadores do vÃrus HIV. Na ampliação do acesso, ... Agência de Notícias da Aids Generic Name: efavirenz, emtricitabine, tenofovir - Nov 11, 2009 Atripla (generic name: efavirenz / emtricitabine / tenofovir disoproxil fumarate) is a combination medicine used alone or with other medicines to treat ... Pattaya Daily News Mylan Inc Subsidiary Matrix Laboratories Receives FDA - Nov 13, 2009 FDA approval for the company's fixed-dose combination of Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate tablets for the treatment of HIV. ... TransWorldNews (press release) FDA Safety Changes: Ultram, Ultracet, Sustiva, Kayexalate - Oct 28, 2009 On September 23, the FDA approved safety labeling revisions for efavirenz capsules and tablets (Sustiva; Bristol-Myers Squibb Co) to warn of drug ... Medscape Gilead Sciences, Inc. Q3 2009 Earnings Call Transcript - Oct 20, 2009 The efavirenz portion of Atripla, which is purchased from BMS at its estimated market price and reflected in cost of goods sold was approximately $222 ... Seeking Alpha (blog) Nitrogen Atom-Directed Ortho-Lithiation Aids Preparation of Anti-HIV Drug - Nov 10, 2009 With the new technology they were able to prepare efavirenz in only three steps and with 68% overall efficiency-a very considerable improvement on the ... AZoNano.com Postexposure Prophylaxis for HIV Infection - Oct 28, 2009 Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in ... New England Journal of Medicine (subscription) Concert Starts HIV Trial, Bags $12M From Glaxo to Help Challenge Gilead's Once ... - Nov 9, 2009 ...be combined with other antivirals to create a convenient once-daily pill to compete with Gilead Sciences' efavirenz emtricitabine tenofovir (Atripla), ... Xconomy FDA Approves Labeling Update for REYATAZ® (atazanavir sulfate) Capsules to ... - Nov 5, 2009 ...fluticasone propionate or voriconazole when REYATAZ is given with ritonavir; and proton-pump inhibitors or efavirenz in treatment-experienced patients. ... WELT ONLINE BristolMyers Squibb Company Reports Operating Results (10-Q) - Oct 22, 2009 Significant contributions to sales growth were also provided by the HIV portfolio (the SUSTIVA Franchise (efavirenz) and REYATAZ(atazanavir sulfate)), ... GuruFocus.com No Heart Rhythm Problem With 25 mg of Rilpivirine - Nov 5, 2009 To explore this further, Simon Vanveggel, PhD, and his colleagues at Tibotec in Antwerp, Belgium, compared rilpivirine with Sustiva (efavirenz) and a ... AIDSmeds.com HIV/AIDS Treatment News RT-SHIV subpopulation dynamics in infected macaques during anti-HIV therapy - Nov 4, 2009 ...treated with short-course efavirenz monotherapy 13 weeks post-infection followed by daily combination antiretroviral therapy (ART) beginning at week 17. ... 7thSpace Interactive (press release) Canada approves ISENTRESS(R) for adults starting HIV treatment - Oct 20, 2009 ...(1) In the STARTMRK study of treatment-naïve patients, raltegravir was found to be as effective as efavirenz (one of the standard antiretrovirals prescribed ... CNW Telbec (Communiqué de presse) B-MS posts strong sales for most of its drugs - Oct 23, 2009 As for the firm's HIV drugs, sales of the Sustiva (efavirenz) franchise rose 7% to $315 million, and Reyataz (atazanavir) was up 5% to $360 million. ... Pharma Times GileadAnnouncesLong-TermDatafromTwo PivotalPhaseIIIStudiesEvaluatingViread ... - Oct 31, 2009 ...be used in combination with Truvada (emtricitabine/tenofovir disoproxil fumarate) or Atripla® (efavirenz/emtricitabine/tenofovir disoproxil fumarate). ... Reuters Intelence® (étravirine) : de rares cas de réactions cutanées sévères - Nov 3, 2009 Dans cette famille, la névirapine (Viramune®) et l'efavirenz (Sustiva®) sont déjà connus pour entraîner des réactions cutanées sévères chez de rares ... ARCAT Alerta VIH - Oct 25, 2009 Cuando fui a buscar mi tratamiento esta semana, me entregaron una presentación distinta de la usual del Efavirenz, llamada Aviranz, producida por el ... El Universal (Venezuela) GileadSciencesgibtRekord-Finanzergebnis für das dritteQuartal2009bekannt - Oct 23, 2009 Diese Umsatzsteigerung wurde primär durch die Antiviral-Sparte von Gilead gefördert, einschließlich des starken Umsatzwachstums bei Atripla® (Efavirenz 600 ... Reuters Le Canada approuve ISENTRESS(MC) pour les adultes commençant un traitement ... - Oct 20, 2009 ...(1) Dans l'étude STARTMRK portant sur les patients n'ayant jamais reçu de traitement, le raltégravir a démontré être aussi efficace que l'efavirenz (l'un ... CNW Telbec (Communiqué de presse) Gilead Sciences gibt Rekord-Finanzergebnis für das dritte Quartal 2009 bekannt - Oct 23, 2009 Diese Umsatzsteigerung wurde primär durch die Antiviral-Sparte von Gilead gefördert, einschließlich des starken Umsatzwachstums bei Atripla ® (Efavirenz 600 ... WELT ONLINE Menipis Obat untuk Pasien HIV di Aceh - Oct 29, 2009 ...sebulan bisa menghabiskan jenis obat Duviral 790 tablet,Neviral 545 tablet, Hiviral 16 tablet, Efavirenz 187 tablet, Reviral 90 tablet dan Coviro 120. ... Portal CBN Comment les médicaments antirétroviraux ont transformé la vie des enfants ... - Nov 4, 2009 Les ARV que nous disposons c'est essentiellement l'AZT, la stavudine, efavirenz, le nevirapine, lamivudine, le Viracept®. ... papamamanbebe.net ä¸å›½åŒ»è?¯äº§ä¸šç«žäº‰åŠ›æž„建与å?¯æŒ?ç»å?‘展 - Nov 2, 2009 ...曲ä¼?沙星（Alatrofloxacin Mesylate），2009å¹´11月美国专利到期；阿巴å?¡éŸ¦ï¼ˆAbacavir），2009å¹´6月美国专利到期；ä¾?å?‘韦仑（Efavirenz），2013å¹´5月美国专利到期。 ... 中国生物技术信息网 Brazil Breaks Patent on Merck's Efavirenz AIDS Drug - May 4, 2007 By Katia Cortes. May 4 (Bloomberg) -- Brazilian President Luiz Inacio Lula da Silva broke the patent on Merck & Co's AIDS drug Efavirenz after the company's ... Bloomberg Merck cuts price on AIDS drug Efavirenz - Feb 15, 2007 BANGKOK (Reuters) - Pharmaceutical giant Merck & Co. announced on Thursday a reduction in the price of its HIV-AIDS drug, Efavirenz, for poor countries and ... Reuters … (MSD) Again Reduces Price of STOCRIN (efavirenz) For Patients in … - Mar 16, 2006 The chemical entity of STOCRIN, efavirenz, was discovered by MSD's research ... Bristol- Myers Squibb has exclusive marketing rights to efavirenz in the ... AllAfrica.com Myelomeningocele in an Infant with Intrauterine Exposure to Efavirenz - Jun 9, 2005 Correspondence: Akihiko Saitoh, University of California, San Diego 9500 Gilman Dr. MC 0672, La Jolla, CA 92093-0672, USA ... Nature.com Efavirenz Superior to Nevirapine for Treating HIV in Coinfected... - Aug 4, 2008 By Ed Susman. MEXICO CITY -- August 4, 2008 -- An efavirenz-based regimen appears more successful than a nevirapine-based regimen in the treatment of human ... DG News Aurobindo Pharma gets US approval for Efavirenz - Jul 4, 2005 AUROBINDO Pharma Ltd on Sunday announced that it has received approval from the US Food and Drug Administration for Efavirenz tablets, 600 mg, ... Hindu Business Line … (FDA) Approves ATRIPLA(TM) (efavirenz 600 mg/ emtricitabine 200... - Jul 12, 2006 ATRIPLA contains 600 mg of efavirenz, a non- nucleoside reverse ... Efavirenz should not be used during the first trimester of pregnancy due to the ... Free with registration - PR Newswire - AccessMyLibrary.com Brazil to Break Patent on Merck's Efavirenz AIDS Drug - May 3, 2007 By Katia Cortes. May 3 (Bloomberg) -- Brazilian President Luiz Inacio Lula da Silva is set to break the patent on Merck & Co's AIDS drug Efavirenz after the ... Bloomberg Efavirenz-Based Initial Therapies Associated with Better Outcomes in... - Oct 14, 2008 Newswise — A study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that HIV-infected patients taking the antiretroviral drug ... newswise.com Thailand breaks patent on Merck's AIDS drug, announces compulsory … - Nov 30, 2006 ...'Efavirenz is currently patent-protected in Thailand, and the resulting monopolistic situation is limiting supply and affordability,' said David Wilson, ... Forbes Bloomberg Printer-Friendly Page - Dec 11, 2007 Efavirenz is marketed by Bristol-Myers Squibb under the tradename SUSTIVA(R) in the ... Efavirenz will continue to be commercialized by Merck & Co, Inc, ... Bloomberg Study Supports Popular HIV Drug Regimen - May 14, 2008 The researchers found that the combination of a drug known as efavirenz (also ... The findings may bolster the use of efavirenz-based treatments in people ... Washington Post Clinton Foundation secures price cuts for efavirenz, abacavir and... - Jan 13, 2006 The Clinton Foundation announced yesterday that it has reached agreement with generic drug manufacturers and makers of rapid HIV antibody tests for large ... Aidsmap Brazil to make generic version of key AIDS drug - Sep 18, 2008 A locally made generic version of Efavirenz, one of 17 drugs in the cocktail ... Efavirenz now accounts for 4 percent of the Health Ministry's AIDS drug ... Reuters India Indian firms to benefit - May 7, 2007 Of them, only 75000 patients are currently treated with efavirenz. ... Efavirenz tablets are used as a frontline anti-retroviral drug to treat human ... Business Standard Clinton expands program for cheaper AIDS drugs - Jan 12, 2006 It will also cut the cost of Efavirenz and Abacavir -- anti-retroviral drugs ... Four companies will offer Efavirenz for $240 per patient per year and one ... CNN Brazil to produce generic AIDS drug - Sep 17, 2008 Jose Gomes Temporao said Wednesday the decision to produce efavirenz, a generic version ... In May of 2007, Brazil bypassed the patent on efavirenz when the ... USA Today Impact of Efavirenz on Neuropsychological Performance and Symptoms … - Nov 15, 2005 Background: Efavirenz is a commonly used antiretroviral drug that causes neurologic side effects in more than 50% of patients. ... Annals of Internal Medicine Xinhua - English - Apr 26, 2007 RIO DE JANEIRO, April 25 (Xinhua) -- Brazil's Ministry of Health announced on Wednesday that it had classified Efavirenz, the anti-retroviral drug used to ... æ–°å?Žç½‘ Gilead, Merck Sign Atripla Pact - Aug 11, 2006 Efavirenz is marketed by Merck under the tradename Stocrin outside the US, Canada and certain European countries. In those places, it's sold by ... TheStreet.com - TheStreet.com (subscription) Generic efavirenz-based regimens provide effective viral load … - Apr 15, 2005 HAART regimens including generic efavirenz provide effective suppression of viral load, increase CD4 cell counts, and are safe and well tolerated, ... Aidsmap Aurobindo gets USFDA nod for HIV drug Efavirenz - Dec 17, 2008 PTI. Mumbai: Aurobindo Pharma today said it has received the US administration's approval to manufacture and market the drug used for treatment of HIV ... Livemint Pharmacokinetics and Pharmacodynamics of Efavirenz and Nelfinavir in ... - Mar 27, 2007 Fifty human immunodeficiency virus (HIV)-infected children participated in an area-under-the plasma concentration–time curve (AUC)-controlled trial of ... Nature.com Efavirenz May Be Best Initial Treatment of HIV-1 Infection - May 15, 2008 May 15, 2008 — In patients with HIV-1 infection, those given efavirenz plus 2 nucleoside reverse transcriptase inhibitors (NRTIs) were less likely to have ... Medscape Efavirenz (Systemic). - Jul 28, 2005 Efavirenz ( eh-FAH-vih-rehnz) is used with other medicines in the treatment of the infection caused by the human immunodeficiency virus (HIV). ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com An Investigational Oral HIV Integrase Inhibitor, MK-0518, in Combinati... - Aug 12, 2006 Results were similar for patients taking the efavirenz combination, ... Baseline HIV RNA for patients in the efavirenz arm of the study was 67554 copies/mL ... Free with registration - Business Wire - AccessMyLibrary.com India's Ranbaxy has 3 more AIDS drugs on WHO list - Sep 10, 2007 The Ranbaxy anti-retroviral drugs added to the list are tablet combinations of lamivudine and zidovudine with a single tablet of efavirenz, and two tablet ... Reuters India Thai ministry OKs AIDS drug patent license - Dec 6, 2006 Efavirenz is marketed by Bristol-Myers Squibb in the US and some European countries under the brand name Sustiva and in other countries by Merck under the ... æ–°å?Žç½‘ Blood concentrations of efavirenz predict who will develop central … - Oct 27, 2005 Spanish researchers have found that patients who have been taking long-term antiretroviral therapy including the non-nucleoside transcriptase inhibitor ... Aidsmap New Merck HIV drug works in untreated patients - Oct 26, 2008 Isentress worked slightly better than an older HIV drug called efavirenz in suppressing levels of the AIDS virus, the researchers told a meeting of the ... Reuters UK HIV patients get first once-a-day pill - Aug 9, 2006 Merck, based in Whitehouse Station, NJ, is involved because it has rights to market one of the three drug ingredients, efavirenz, under the brand name ... msnbc.com Efavirenz reduces blood statin concentrations - Jun 29, 2005 Taking efavirenz (Sustiva) at the same time as the lipid-lowering statin drugs simvastatin (Zocor), atorvastatin (Lipitor) or pravastatin (Lipostat) results ... Aidsmap … Price Of Antiretroviral Efavirenz In Thailand, Provide No-Cost... - Jun 7, 2007 Merck has offered to reduce the price of its antiretroviral drug Efavirenz in Thailand, Vichai Chokewiwat, chair of the Government Pharmaceutical ... Medical News Today - Medical News Today (press release) New Thai govt to review drug patent plan - Feb 7, 2008 Former Health Minister Mongkol na Songkhla overrode Merck's AIDS drug Efavirenz in late 2006, arguing that Thailand could not afford patented drugs for a ... Reuters Atripla Makers Seek European Approval - Oct 9, 2006 The once-daily pill combines efavirenz, sold under the Bristol trade name ... Efavirenz is sold in a number of countries by Merck under the name Stocrin. ... TheStreet.com - TheStreet.com (subscription) Tentative USFDA nod for Aurobindo's 3rd AIDS drug - Jun 26, 2005 In the treatment of HIV-1 infection, Efavirenz is generally used in combination with other antiretroviral drugs. According to the Aurobindo official, ... Hindu Business Line Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine … - Oct 17, 2007 Bristol-Myers Squibb Company (NYSE:BMY) and Gilead Sciences, Inc. (Nasdaq:GILD) announced today that Health Canada has approved ATRIPLA(R) (efavirenz 600 ... Genetic Engineering News - Genetic Engineering News (press release) 'Generic ARV will cut HIV costs' - Jun 3, 2008 Compared with a year's supply of efavirenz at $500, a generic equivalent of proven quality, safety and efficacy could cost only $150. Independent Online Researchers find better HIV medication - Jan 19, 2006 The therapy was compared to the combination of zidovudine, lamivudine (AZT and 3TC, or Combivir), and efavirenz. One-year use of the therapy has also led to ... æ–°å?Žç½‘ Thailand to buy generic rivals to Sanofi-Aventis', Bristol-Myers... - Aug 22, 2007 It has already begun importing cheaper versions of Efavirenz from India, a major source of generic drugs. Earlier this month, European Union Trade ... Forbes … disorders can persist for two years after starting efavirenz - Apr 6, 2005 Mild neuropsychiatric disturbances can persist for up to two years after starting efavirenz (Sustiva), according to a study published in the April 15 th ... Aidsmap Efavirenz-based therapies associated with better outcomes in HIV- … - Oct 15, 2008 New technique could eliminate inherited mitochondrial disease — [26 Aug 2009] — Researchers have developed an experimental technique with the potential to ... Science Centric Efavirenz and rifampicin: UK doctors caution on higher EFV doses in … - Sep 8, 2005 Clinicians at St George's Hospital in London report that patients are much more likely to experience efavirenz-related side-effects when 800mg efavirenz ... Aidsmap Brazil's Aids policy 'remarkable' - Nov 14, 2007 Earlier this year Brazil broke the patent on the Aids drug Efavirenz and decided to import a cheaper version from India. Drugs companies have warned that ... BBC News Glaxo cuts HIV drug prices for poor countries - Feb 19, 2008 The decision comes after Thailand stunned drug makers in late 2006 when it overrode the patent on Merck's AIDS drug Efavirenz, arguing it could not afford ... Reuters Large analysis shows benefits of starting treatment with efavirenz - Aug 23, 2006 An analysis of twelve European and North American cohort studies has found that HIV-positive patients starting treatment containing efavirenz (Sustiva) may ... Aidsmap Neurological side-effects of efavirenz mild and transient, study... - Dec 12, 2005 HIV-positive patients taking efavirenz (Sustiva) tend to experience neurological side-effects such as bad dreams soon after starting treatment, ... Aidsmap Learn about Efavirenz from Consumer Reports Health. - Jan 6, 2007 Efavirenz is used with other medications to treat human immunodeficiency virus (HIV) infection in patients with or without acquired immunodeficiency ... consumerreports.org Efavirenz/Emtricitabine/Tenofovir Tablets (Atriplaâ„¢) - Sep 29, 2006 By William T. Elliott, MD, FACP, and James Chan, PhD, PharmD, Dr. Elliott is Chair, Formulary Committee, Northern California Kaiser Permanente; ... Free with registration - Internal Medicine Alert - AccessMyLibrary.com IAC: Efavirenz (Sustiva) the Pick in Severely Immunocompromised … - Aug 5, 2008 By Michael Smith, North American Correspondent, MedPage Today. MEXICO CITY, Aug. 5 -- In HIV patients who begin treatment with a damaged immune system, ... MedPage Today Efavirenz may linger for up to eight weeks after treatment stops - Sep 28, 2005 Levels of efavirenz (Sustiva) sufficient to cause drug resistance may linger for at least eight weeks after it is stopped in some people who have a genetic ... Aidsmap Thailand Expected to Break Patents on Two Drugs - Jan 25, 2007 Late last year, Thailand ordered compulsory licensing for Efavirenz, an antiretroviral AIDS drug. A report issued jointly in August last year by the World ... FOXNews Efavirenz-based Tx better at reducing viral load: the best regimen... - Sep 15, 2006 TORONTO -- A large, randomized comparison of three standard regimens for the initial treatment of HIV has demonstrated that all three are safe and effective ... Free with registration - Family Practice News - AccessMyLibrary.com … Treatment Failure Compared to Efavirenz-Based Combination: Presented - Aug 8, 2008 The efavirenz-based treatment was shown to be "conclusively" better than a more ... Results from the third arm in the study -- containing efavirenz, ... DG News Generic efavirenz approved for PEPFAR use but 4 African countries... - Jun 28, 2005 The United States Food and Drug Administration (FDA) announced on Friday that it had granted tentative approval for efavirenz tablets manufactured by ... Aidsmap … Positive Opinion For ATRIPLA(R) (Efavirenz 600mg/Emtricitabine 200... - Oct 22, 2007 Efavirenz is marketed by Bristol-Myers Squibb under the tradename SUSTIVA(R) ... In addition to efavirenz, factors identified in a clinical study that were ... Medical News Today - Medical News Today (press release) Variation in gene linked to risk of resistance after stopping efaviren... - Apr 10, 2006 The non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz is a component of ... However, a drawback of the use of efavirenz is the development of ... Aidsmap East Cape firm's ARVs help Aids patients - Jun 28, 2008 In addition to maintaining the supply contract for existing tender items, Aspen has also secured volumes for two new products, Aspen Efavirenz and Tenofivir ... Dispatch Online Thailand threatens to produce more copycat drugs - Feb 12, 2007 ...who first angered drug companies in November by issuing Thailand's first such license for Merck's Efavirenz anti-retroviral AIDS treatment. ... Reuters India's Strides Arcolab gets FDA nod for two HIV/AIDS new drug … - Jun 6, 2007 ...combination of Lamivudine/Stavudine 150 mg/40 mg tablets and Lamivudine/Zidovudine 150/300 mg tablets, each co-packaged with Efavirenz 600 mg tablets. ... Forbes … Shows Improved Lipid Profile Compared With Efavirenz: Presented at... - Jul 25, 2007 ..."TMC278 resulted in minimal changes in lipid profiles after 1 year of treatment and may have a potential benefit versus efavirenz," said Kiat Ruxrungtham, ... DG News Integrase Inhibitor Raltegravir as Effective as Efavirenz-Based... - Jul 25, 2007 By Ed Susman. SYDNEY, AUSTRALIA -- July 25, 2007 - Close to 90% of patients treated with either the novel integrase inhibitor raltegravir or the ... DG News Efavirenz (Systemic).(Drug overview) - May 1, 2006 Efavirenz ( eh-FAH-vih-rehnz) is used with other medicines in the treatment of the infection caused by the human immunodeficiency virus (HIV). ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Aurobindo receives approval of Efavirenz - Dec 22, 2006 Aurobindo Pharma Limited is pleased to announce that the company has received tentative approval from the USFDA for Efavirenz capsules, 50 mg, ... Moneycontrol.com Ranbaxy to launch HIV drug combo in India - Nov 30, 2005 Virolis-E contains two fixed dose combination tablets of Lamivudine and Stavudine and one tablet of Efavirenz. Virocomb-E consists of two combination ... United Press International First-line Approaches For Treating HIV Evaluated By Clinical Trial - Aug 15, 2006 ..."Our findings suggest that the efavirenz plus two-NRTI regimen was the best ... "Also, we found that the NRTI-sparing two-drug combination of efavirenz and ... Medical News Today - Medical News Today (press release) Strides Arcolab gets USFDA nod for efavirenz tablets - Mar 28, 2007 Strides Arcolab announced on Mar.28, 2007 that the company has received a tentative approval from the United States - Food and Drug Administration (USFDA) ... Myiris.com New, more efficient anti-AIDS drug for untreated patients - Oct 28, 2008 Drug-related adverse effects were also significantly fewer in patients treated with Isentress (44 percent) than with efavirenz (77 percent), the researchers ... Tehran Times IAS: Maraviroc Called Premature for New HIV Patients - Jul 25, 2007 But the CCR5 antagonist had better safety results than efavirenz, which is regarded ... 13.6% of efavirenz patients dropped out because of adverse events, ... MedPage Today … suggests many children could have subtherapeutic levels of efaviren... - Jun 6, 2007 Many children could have subtherapeutic concentrations of efavirenz in their blood, according to a small South African study published in the June 1 st ... Aidsmap CROI: Therapeutic concentrations of efavirenz, Kaletra, could be... - Mar 7, 2007 Therapeutic concentrations of some antiretrovirals could be difficult to achieve in some HIV-infected children in resource-limited settings according to a ... Aidsmap Pfizer's maraviroc fares well vs efavirenz. - Aug 6, 2007 Pfizer's maraviroc fares well vs efavirenz. World drug giant Pfizer says that rates of virologic suppression in patients receiving its novel CCR5 antagonist ... $9.94 - Pharma Marketletter - Alacra Store Merck cuts price of efavirenz for developing countries again - Feb 16, 2007 Merck & Co has cut the price of efavirenz 600mg tablets (Stocrin) for developing countries that qualify for its access programme, the company announced ... Aidsmap Merck announces 20% cut in efavirenz price for low and middle-income ... - Mar 7, 2006 Merck Sharp and Dohme (MSD) is to reduce the price of efavirenz (Sustiva) by 20% in least-developed countries and other middle income countries with severe ... Aidsmap Atripla: efavirenz/emtricitabine/tenofovir disoproxil tablets.(New … - Aug 1, 2006 This fixed-dose combination tablet contains: efavirenz, a non-nucleoside reverse transcriptase inhibitor (NNRTI); emtricitabine, a synthetic nucleoside ... Free with registration - Formulary - AccessMyLibrary.com Government to Break Patent On Key Aids Drug - Dec 4, 2006 ..."If they can reduce the cost of Efavirenz by the amount they say they can, it means the budget they've got can treat a lot more people," said Paul Cawthorne ... AllAfrica.com Gilead and BMS to seek regulatory approval for efavirenz, Truvada … - Jan 10, 2006 Multi-class HIV treatment consisting of just one pill once a day came step closer to becoming reality yesterday as drug companies Gilead Sciences and ... Aidsmap Rifampicin Has No Long-Term Effect on Antiviral Efficacy of Efavirenz... - Jul 23, 2007 ..."Rifampicin reduces the exposure to efavirenz by up to 20%, but the reduction is more marked in individuals with higher body weight," Dr. Patel noted during ... Medscape Ranbaxy in-licences Tramadol; gets WHO nod for 4 more ARVs - May 24, 2006 He further added, “Efavirenz is rapidly becoming a preferred drug in HIV treatment program in developing countries. The other newly listed drug, Stavudine, ... Business Standard Mmegi Online ::> news we need to know - Jan 24, 2006 ...and nausea compared to use of another widely used combination of antiretrovirals, zidovudine and lamivudine (AZT and 3TC, or Combivir), plus efavirenz. ... Mmegi Online INDONESIA: Trying to solve ARV supply woes - Jul 16, 2008 The supply of efavirenz recently dried up, leading to a demonstration by about ... Around 60 percent of people living with HIV are thought to use efavirenz. ... Reuters AlertNet Four Ranbaxy HIV/AIDS drugs in WHO pre-qualification list - May 25, 2006 The products approved by WHO are Efavirenz 600 mg tablets, Efavirenz 200 mg ... "Efavirenz is rapidly becoming a preferred drug in the HIV treatment ... Hindu Business Line Study Compares First-Line Drug Therapies For Treating HIV - Aug 8, 2006 ..."Our findings suggest that the efavirenz plus two-NRTI regimen was the best ... "Also, we found that the NRTI-sparing two-drug combination of efavirenz and ... newswise.com … with history of depression more likely to stop efavirenz due to... - Jul 26, 2006 The investigators note that many of the patients stopping efavirenz because ... Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that ... Aidsmap Sustiva Use During Pregnancy May Cause Fetal Harm - Jun 14, 2005 In animal studies of efavirenz, malformations were observed in 3 (15%) of 20 ... In these monkeys, efavirenz crossed the placenta to produce fetal blood ... Medscape … and phenytoin can result in undetectable blood levels of efavirenz - Jan 3, 2008 US investigators have reported a significant interaction between efavirenz (Sustiva) and phenytoin, an anti-epilepsy drug. The case is reported in the ... Aidsmap Frequency of Late CNS Side Effects from Efavirenz - Jan 27, 2006 Spanish researchers found that high plasma efavirenz levels correlated with CNS symptoms even after weeks or months of treatment. However, in a substudy of ... Medscape Switching From Stavudine to Efavirenz Maintains Long-Term Control of ... - Aug 7, 2008 By Ed Susman. MEXICO CITY -- August 7, 2008 -- Switching patients with human immunodeficiency virus (HIV) from a backbone regimen that includes stavudine to ... DG News … sustained potency, better CNS and lipid profile than efavirenz, in... - Mar 2, 2007 When compared with efavirenz (Sustiva), Tibotec's investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) TMC278 demonstrated equally potent ... Aidsmap Study finds no link between efavirenz use and depression - May 30, 2006 French researchers have found that patients taking efavirenz (Sustiva) do not have a greater risk of depression than those taking a protease inhibitor-based ... Aidsmap Africa: Daily HIV/Aids Report - Apr 16, 2007 Merck also offered to reduce the price of its antiretroviral Efavirenz to $23 per bottle, but the government can purchase a generic version of the drug from ... AllAfrica.com Manto is talking nonsense - TAC - Aug 8, 2007 Geffen said one combination uses stavudine (D4T), lamivudine and nevirapine, at a cost of about R110 a month per patient, while the other uses efavirenz ... Independent Online Second line of attack - May 22, 2007 Brazil, for instance, plans to import a cheaper, generic version of efavirenz from India instead of buying it from Merck. ... Business Standard Rare gene causes massive increases in efavirenz levels in twelve-year... - Oct 8, 2007 A rare genetic mutation meant that a twelve-year-old girl had seven-to-eight times the normal blood concentration of efavirenz (Sustiva) leading to ... Aidsmap … viral load more likely with nevirapine than efavirenz if ART... - Nov 19, 2007 Some suggested using efavirenz only at a higher dose — but data have shown ... There was no major difference in responses between patients on efavirenz with ... Aidsmap EFAVIRENZ (Oral route) - ef-a-VYE-renz.(Drug overview) - May 1, 2007 Efavirenz is used with other medicines in the treatment of the infection caused by the human immunodeficiency virus (HIV). HIV is the virus that causes ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com … Issues Positive Opinion For ATRIPLA(R) (efavirenz 600 Mg/ Emtricita... - Oct 19, 2007 Efavirenz is marketed by Bristol-Myers Squibb under the tradename SUSTIVA(R) ... In addition to efavirenz, factors identified in a clinical study that were ... Medical News Today - Medical News Today (press release) Pharmacokinetic factors and the discontinuation of efavirenz - Mar 31, 2006 Patients stopping efavirenz-based combination therapy might be well advised to continue their NRTIs for 24 to 48 hours after discontinuing efavirenz to ... Medscape How India deals with the case for compulsory licence will be keenly … - Jan 30, 2008 And last year, Brazil followed suit for Efavirenz after negotiations with Merck to lower prices did not secure it discount that it felt was justified. ... Livemint Thai PM goes on defensive in generic drugs rumpus - May 4, 2007 Thailand has issued such licenses for AIDS drugs Kaletra and Efavirenz and heart disease medicine Plavix and plans to import generic versions of the drugs ... The Standard Brand Names/Synonyms: Efavirenz is also known by the following brand names and/or synonymsDMP 266; DMP-266; EFV; Efavirenz; Stocrin; Sustiva Drug Category: Efavirenz is categorized under the following by the FDA: Anti-HIV Agents; Nonnucleoside Reverse Transcriptase Inhibitors; ATC:J05AG03 Dosage Forms: TABLET, CAPSULE Absorption: Not Available Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 8-chloro-5-(2-cyclopropylethynyl)-5-(trifluoromethyl)-4-oxa-2-azabicyclo[4.4.0]deca-7,9,11-trien-3-one |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
